Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1/2 Mutation Carriers

Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidates for risk-reducing prophylactic bilateral salpingo-oophorectomy (PBSO). The aim of the current study was to identify baseline predictors of PBSO versus gynecologic screening (GS) in this group of high-risk w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical oncology 2007-01, Vol.25 (3), p.301-307
Hauptverfasser: MADALINSKA, Joanna B, VAN BEURDEN, Marc, BOONSTRA, Henk, AARONSON, Neil K, BLEIKER, Eveline M. A, VALDIMARSDOTTIR, Heiddis B, LUBSEN-BRANDSMA, Lottie, MASSUGER, Leon F, MOURITS, Marian J. E, GAARENSTROOM, Katja N, VAN DORST, Eleonora B. L, VAN DER PUTTEN, Hans
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 307
container_issue 3
container_start_page 301
container_title Journal of clinical oncology
container_volume 25
creator MADALINSKA, Joanna B
VAN BEURDEN, Marc
BOONSTRA, Henk
AARONSON, Neil K
BLEIKER, Eveline M. A
VALDIMARSDOTTIR, Heiddis B
LUBSEN-BRANDSMA, Lottie
MASSUGER, Leon F
MOURITS, Marian J. E
GAARENSTROOM, Katja N
VAN DORST, Eleonora B. L
VAN DER PUTTEN, Hans
description Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidates for risk-reducing prophylactic bilateral salpingo-oophorectomy (PBSO). The aim of the current study was to identify baseline predictors of PBSO versus gynecologic screening (GS) in this group of high-risk women. Baseline questionnaires were available from 160 BRCA1/2 carriers who participated in a nationwide, longitudinal, observational study of the psychosocial consequences of prophylactic surgery versus periodic screening. Topics addressed by the questionnaire included generic quality of life, cancer-specific distress, risk perception, knowledge of ovarian cancer, and perceived pros and cons of surgery versus screening. PBSO use during the 12-month period after the first gynecologic consultation was determined on the basis of medical record data. During the 12-month follow-up period, 74% of women had undergone PBSO, and 26% opted for screening. Statistically significant multivariate predictors of PBSO included education, general health perceptions, perceived incurability of ovarian cancer, and perceived benefits of surgery. Women with lower educational levels, with poorer general health perceptions, who view ovarian cancer as an incurable disease, and who believe more strongly in the benefits of surgery are more likely to undergo PBSO. Clinicians should ensure that high-risk women are well informed about the low predictive value of GS techniques and about the lethal threat posed by ovarian cancer because of its limited curability.
doi_str_mv 10.1200/JCO.2006.07.4922
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68931614</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68931614</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-65f71c41d68ae1c0692095b91c532b5de4a1723eacb258637286d4d3231f57983</originalsourceid><addsrcrecordid>eNpFkM1v0zAYhy0EYt3gzgn5Ard0_ojj5LhFsIGGOjEmuFlvnTetJyfO7FSoJ_51XK1ST-_Bz_OT_BDygbMlF4xdfm9Xy3yrJdPLshHiFVlwJXShtVKvyYJpKQpeyz9n5DylJ8Z4WUv1lpxxLaRipVqQf_cRO2fnEBMNPb2PYdruPdjZWXrtPMwYwdMH8JMbN6FY5ecQMfPDnrZhmCDr9Lebt_RmP6INPmyy-WAj4pgN-piQupFe_2yv-KWgP3YzzC6MtIUYHcb0jrzpwSd8f7wX5PHrl1_tbXG3uvnWXt0VVjbNXFSq19yWvKtqQG5Z1QjWqHXDrZJirTos4fAnBLsWqq6kFnXVlZ0UkvdKN7W8IJ9fdqcYnneYZjO4ZNF7GDHskqnqRvKKlxlkL6CNIaWIvZmiGyDuDWfmEN3k6OYQ3TBtDtGz8vG4vVsP2J2EY-UMfDoCkCz4PsJoXTpxdamllOzEbd1m-9dFNGkA7_OsME82CGWkkYzL_1P_luE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68931614</pqid></control><display><type>article</type><title>Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1/2 Mutation Carriers</title><source>MEDLINE</source><source>American Society of Clinical Oncology Online Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>MADALINSKA, Joanna B ; VAN BEURDEN, Marc ; BOONSTRA, Henk ; AARONSON, Neil K ; BLEIKER, Eveline M. A ; VALDIMARSDOTTIR, Heiddis B ; LUBSEN-BRANDSMA, Lottie ; MASSUGER, Leon F ; MOURITS, Marian J. E ; GAARENSTROOM, Katja N ; VAN DORST, Eleonora B. L ; VAN DER PUTTEN, Hans</creator><creatorcontrib>MADALINSKA, Joanna B ; VAN BEURDEN, Marc ; BOONSTRA, Henk ; AARONSON, Neil K ; BLEIKER, Eveline M. A ; VALDIMARSDOTTIR, Heiddis B ; LUBSEN-BRANDSMA, Lottie ; MASSUGER, Leon F ; MOURITS, Marian J. E ; GAARENSTROOM, Katja N ; VAN DORST, Eleonora B. L ; VAN DER PUTTEN, Hans</creatorcontrib><description>Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidates for risk-reducing prophylactic bilateral salpingo-oophorectomy (PBSO). The aim of the current study was to identify baseline predictors of PBSO versus gynecologic screening (GS) in this group of high-risk women. Baseline questionnaires were available from 160 BRCA1/2 carriers who participated in a nationwide, longitudinal, observational study of the psychosocial consequences of prophylactic surgery versus periodic screening. Topics addressed by the questionnaire included generic quality of life, cancer-specific distress, risk perception, knowledge of ovarian cancer, and perceived pros and cons of surgery versus screening. PBSO use during the 12-month period after the first gynecologic consultation was determined on the basis of medical record data. During the 12-month follow-up period, 74% of women had undergone PBSO, and 26% opted for screening. Statistically significant multivariate predictors of PBSO included education, general health perceptions, perceived incurability of ovarian cancer, and perceived benefits of surgery. Women with lower educational levels, with poorer general health perceptions, who view ovarian cancer as an incurable disease, and who believe more strongly in the benefits of surgery are more likely to undergo PBSO. Clinicians should ensure that high-risk women are well informed about the low predictive value of GS techniques and about the lethal threat posed by ovarian cancer because of its limited curability.</description><identifier>ISSN: 0732-183X</identifier><identifier>EISSN: 1527-7755</identifier><identifier>DOI: 10.1200/JCO.2006.07.4922</identifier><identifier>PMID: 17235045</identifier><language>eng</language><publisher>Baltimore, MD: American Society of Clinical Oncology</publisher><subject>Adult ; Aged ; Attitude to Health ; Biological and medical sciences ; Educational Status ; Fallopian Tubes - surgery ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Genetic Testing ; Health Care Surveys ; Humans ; Longitudinal Studies ; Medical sciences ; Middle Aged ; Ovarian Neoplasms - genetics ; Ovarian Neoplasms - prevention &amp; control ; Ovariectomy ; Predictive Value of Tests ; Prognosis ; Quality of Life ; Tumors</subject><ispartof>Journal of clinical oncology, 2007-01, Vol.25 (3), p.301-307</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-65f71c41d68ae1c0692095b91c532b5de4a1723eacb258637286d4d3231f57983</citedby><cites>FETCH-LOGICAL-c399t-65f71c41d68ae1c0692095b91c532b5de4a1723eacb258637286d4d3231f57983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3729,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18473330$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17235045$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MADALINSKA, Joanna B</creatorcontrib><creatorcontrib>VAN BEURDEN, Marc</creatorcontrib><creatorcontrib>BOONSTRA, Henk</creatorcontrib><creatorcontrib>AARONSON, Neil K</creatorcontrib><creatorcontrib>BLEIKER, Eveline M. A</creatorcontrib><creatorcontrib>VALDIMARSDOTTIR, Heiddis B</creatorcontrib><creatorcontrib>LUBSEN-BRANDSMA, Lottie</creatorcontrib><creatorcontrib>MASSUGER, Leon F</creatorcontrib><creatorcontrib>MOURITS, Marian J. E</creatorcontrib><creatorcontrib>GAARENSTROOM, Katja N</creatorcontrib><creatorcontrib>VAN DORST, Eleonora B. L</creatorcontrib><creatorcontrib>VAN DER PUTTEN, Hans</creatorcontrib><title>Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1/2 Mutation Carriers</title><title>Journal of clinical oncology</title><addtitle>J Clin Oncol</addtitle><description>Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidates for risk-reducing prophylactic bilateral salpingo-oophorectomy (PBSO). The aim of the current study was to identify baseline predictors of PBSO versus gynecologic screening (GS) in this group of high-risk women. Baseline questionnaires were available from 160 BRCA1/2 carriers who participated in a nationwide, longitudinal, observational study of the psychosocial consequences of prophylactic surgery versus periodic screening. Topics addressed by the questionnaire included generic quality of life, cancer-specific distress, risk perception, knowledge of ovarian cancer, and perceived pros and cons of surgery versus screening. PBSO use during the 12-month period after the first gynecologic consultation was determined on the basis of medical record data. During the 12-month follow-up period, 74% of women had undergone PBSO, and 26% opted for screening. Statistically significant multivariate predictors of PBSO included education, general health perceptions, perceived incurability of ovarian cancer, and perceived benefits of surgery. Women with lower educational levels, with poorer general health perceptions, who view ovarian cancer as an incurable disease, and who believe more strongly in the benefits of surgery are more likely to undergo PBSO. Clinicians should ensure that high-risk women are well informed about the low predictive value of GS techniques and about the lethal threat posed by ovarian cancer because of its limited curability.</description><subject>Adult</subject><subject>Aged</subject><subject>Attitude to Health</subject><subject>Biological and medical sciences</subject><subject>Educational Status</subject><subject>Fallopian Tubes - surgery</subject><subject>Female</subject><subject>Genes, BRCA1</subject><subject>Genes, BRCA2</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetic Testing</subject><subject>Health Care Surveys</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Ovarian Neoplasms - prevention &amp; control</subject><subject>Ovariectomy</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Quality of Life</subject><subject>Tumors</subject><issn>0732-183X</issn><issn>1527-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM1v0zAYhy0EYt3gzgn5Ard0_ojj5LhFsIGGOjEmuFlvnTetJyfO7FSoJ_51XK1ST-_Bz_OT_BDygbMlF4xdfm9Xy3yrJdPLshHiFVlwJXShtVKvyYJpKQpeyz9n5DylJ8Z4WUv1lpxxLaRipVqQf_cRO2fnEBMNPb2PYdruPdjZWXrtPMwYwdMH8JMbN6FY5ecQMfPDnrZhmCDr9Lebt_RmP6INPmyy-WAj4pgN-piQupFe_2yv-KWgP3YzzC6MtIUYHcb0jrzpwSd8f7wX5PHrl1_tbXG3uvnWXt0VVjbNXFSq19yWvKtqQG5Z1QjWqHXDrZJirTos4fAnBLsWqq6kFnXVlZ0UkvdKN7W8IJ9fdqcYnneYZjO4ZNF7GDHskqnqRvKKlxlkL6CNIaWIvZmiGyDuDWfmEN3k6OYQ3TBtDtGz8vG4vVsP2J2EY-UMfDoCkCz4PsJoXTpxdamllOzEbd1m-9dFNGkA7_OsME82CGWkkYzL_1P_luE</recordid><startdate>20070120</startdate><enddate>20070120</enddate><creator>MADALINSKA, Joanna B</creator><creator>VAN BEURDEN, Marc</creator><creator>BOONSTRA, Henk</creator><creator>AARONSON, Neil K</creator><creator>BLEIKER, Eveline M. A</creator><creator>VALDIMARSDOTTIR, Heiddis B</creator><creator>LUBSEN-BRANDSMA, Lottie</creator><creator>MASSUGER, Leon F</creator><creator>MOURITS, Marian J. E</creator><creator>GAARENSTROOM, Katja N</creator><creator>VAN DORST, Eleonora B. L</creator><creator>VAN DER PUTTEN, Hans</creator><general>American Society of Clinical Oncology</general><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070120</creationdate><title>Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1/2 Mutation Carriers</title><author>MADALINSKA, Joanna B ; VAN BEURDEN, Marc ; BOONSTRA, Henk ; AARONSON, Neil K ; BLEIKER, Eveline M. A ; VALDIMARSDOTTIR, Heiddis B ; LUBSEN-BRANDSMA, Lottie ; MASSUGER, Leon F ; MOURITS, Marian J. E ; GAARENSTROOM, Katja N ; VAN DORST, Eleonora B. L ; VAN DER PUTTEN, Hans</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-65f71c41d68ae1c0692095b91c532b5de4a1723eacb258637286d4d3231f57983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Attitude to Health</topic><topic>Biological and medical sciences</topic><topic>Educational Status</topic><topic>Fallopian Tubes - surgery</topic><topic>Female</topic><topic>Genes, BRCA1</topic><topic>Genes, BRCA2</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetic Testing</topic><topic>Health Care Surveys</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Ovarian Neoplasms - prevention &amp; control</topic><topic>Ovariectomy</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Quality of Life</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MADALINSKA, Joanna B</creatorcontrib><creatorcontrib>VAN BEURDEN, Marc</creatorcontrib><creatorcontrib>BOONSTRA, Henk</creatorcontrib><creatorcontrib>AARONSON, Neil K</creatorcontrib><creatorcontrib>BLEIKER, Eveline M. A</creatorcontrib><creatorcontrib>VALDIMARSDOTTIR, Heiddis B</creatorcontrib><creatorcontrib>LUBSEN-BRANDSMA, Lottie</creatorcontrib><creatorcontrib>MASSUGER, Leon F</creatorcontrib><creatorcontrib>MOURITS, Marian J. E</creatorcontrib><creatorcontrib>GAARENSTROOM, Katja N</creatorcontrib><creatorcontrib>VAN DORST, Eleonora B. L</creatorcontrib><creatorcontrib>VAN DER PUTTEN, Hans</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MADALINSKA, Joanna B</au><au>VAN BEURDEN, Marc</au><au>BOONSTRA, Henk</au><au>AARONSON, Neil K</au><au>BLEIKER, Eveline M. A</au><au>VALDIMARSDOTTIR, Heiddis B</au><au>LUBSEN-BRANDSMA, Lottie</au><au>MASSUGER, Leon F</au><au>MOURITS, Marian J. E</au><au>GAARENSTROOM, Katja N</au><au>VAN DORST, Eleonora B. L</au><au>VAN DER PUTTEN, Hans</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1/2 Mutation Carriers</atitle><jtitle>Journal of clinical oncology</jtitle><addtitle>J Clin Oncol</addtitle><date>2007-01-20</date><risdate>2007</risdate><volume>25</volume><issue>3</issue><spage>301</spage><epage>307</epage><pages>301-307</pages><issn>0732-183X</issn><eissn>1527-7755</eissn><abstract>Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidates for risk-reducing prophylactic bilateral salpingo-oophorectomy (PBSO). The aim of the current study was to identify baseline predictors of PBSO versus gynecologic screening (GS) in this group of high-risk women. Baseline questionnaires were available from 160 BRCA1/2 carriers who participated in a nationwide, longitudinal, observational study of the psychosocial consequences of prophylactic surgery versus periodic screening. Topics addressed by the questionnaire included generic quality of life, cancer-specific distress, risk perception, knowledge of ovarian cancer, and perceived pros and cons of surgery versus screening. PBSO use during the 12-month period after the first gynecologic consultation was determined on the basis of medical record data. During the 12-month follow-up period, 74% of women had undergone PBSO, and 26% opted for screening. Statistically significant multivariate predictors of PBSO included education, general health perceptions, perceived incurability of ovarian cancer, and perceived benefits of surgery. Women with lower educational levels, with poorer general health perceptions, who view ovarian cancer as an incurable disease, and who believe more strongly in the benefits of surgery are more likely to undergo PBSO. Clinicians should ensure that high-risk women are well informed about the low predictive value of GS techniques and about the lethal threat posed by ovarian cancer because of its limited curability.</abstract><cop>Baltimore, MD</cop><pub>American Society of Clinical Oncology</pub><pmid>17235045</pmid><doi>10.1200/JCO.2006.07.4922</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0732-183X
ispartof Journal of clinical oncology, 2007-01, Vol.25 (3), p.301-307
issn 0732-183X
1527-7755
language eng
recordid cdi_proquest_miscellaneous_68931614
source MEDLINE; American Society of Clinical Oncology Online Journals; EZB-FREE-00999 freely available EZB journals
subjects Adult
Aged
Attitude to Health
Biological and medical sciences
Educational Status
Fallopian Tubes - surgery
Female
Genes, BRCA1
Genes, BRCA2
Genetic Predisposition to Disease
Genetic Testing
Health Care Surveys
Humans
Longitudinal Studies
Medical sciences
Middle Aged
Ovarian Neoplasms - genetics
Ovarian Neoplasms - prevention & control
Ovariectomy
Predictive Value of Tests
Prognosis
Quality of Life
Tumors
title Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1/2 Mutation Carriers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T02%3A42%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictors%20of%20Prophylactic%20Bilateral%20Salpingo-Oophorectomy%20Compared%20With%20Gynecologic%20Screening%20Use%20in%20BRCA1/2%20Mutation%20Carriers&rft.jtitle=Journal%20of%20clinical%20oncology&rft.au=MADALINSKA,%20Joanna%20B&rft.date=2007-01-20&rft.volume=25&rft.issue=3&rft.spage=301&rft.epage=307&rft.pages=301-307&rft.issn=0732-183X&rft.eissn=1527-7755&rft_id=info:doi/10.1200/JCO.2006.07.4922&rft_dat=%3Cproquest_cross%3E68931614%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68931614&rft_id=info:pmid/17235045&rfr_iscdi=true